Frontiers in Oncology,
Год журнала:
2024,
Номер
14
Опубликована: Окт. 29, 2024
Glioma
represents
the
most
prevalent
primary
malignant
tumor
in
central
nervous
system,
a
deeper
understanding
of
underlying
molecular
mechanisms
driving
glioma
is
imperative
for
guiding
future
treatment
strategies.
Emerging
evidence
has
implicated
close
relationship
between
development
and
epigenetic
regulation.
However,
there
remains
significant
lack
comprehensive
summaries
this
domain.
This
study
aims
to
analyze
publications
pertaining
gliomas
from
2009
2024
using
bibliometric
methods,
consolidate
extant
research,
delineate
prospects
investigation
critical
area.
Asian Journal of Pharmaceutical Sciences,
Год журнала:
2025,
Номер
20(2), С. 101040 - 101040
Опубликована: Фев. 27, 2025
Cellular
hitchhiking
is
an
emerging
therapeutic
strategy
that
uses
endogenous
cell
migration
mechanism
to
deliver
therapeutics
specific
sites
in
the
body.
Owing
low
permeability
and
presence
of
blood-brain
barrier
(BBB),
targeted
delivery
limited,
leading
inadequate
localization
brain.
NCs
fail
extravasate
significantly
into
tumor
microenvironment
(TME),
demonstrating
poor
accumulation
penetration.
The
novel
cellular
concept
has
been
utilized
promote
systemic
half-life
targeting.
Neoplastic
neuroinflammatory
diseases
brain,
including
glioblastoma
neuroinflammation,
face
critical
hurdles
for
efficiently
delivering
entities
owing
BBB.
can
surmount
these
by
utilizing
various
populations,
such
as
stem
cells,
monocytes/macrophages,
neutrophils,
platelets,
potential
functional
carriers
cargo
through
These
carrier
cells
have
innate
capability
traverse
BBB,
transit
brain
parenchyma,
specifically
reach
disease
inflammatory
neoplastic
lesions
chemotactic
navigation,
i.e.,
movement
attributed
chemical
stimuli.
Chemotherapeutic
drugs
delivered
achieve
tumor-specific
targeting
discussed.
This
article
explores
types
TME
with
in-depth
mechanisms
characterization
techniques
decipher
backpack
dissociation
dynamics
(nanoparticle
payload
detachment
characteristics
from
hitchhiked
cells)
challenges
toward
prospective
clinical
translation.
Advanced Materials,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 10, 2025
Abstract
Metastasis,
the
leading
cause
of
mortality
in
cancer
patients,
presents
challenges
for
conventional
photodynamic
therapy
(PDT)
due
to
its
reliance
on
localized
light
and
oxygen
application
tumors.
To
overcome
these
limitations,
a
self‐sustained
organelle‐mimicking
nanoreactor
is
developed
here
with
programmable
DNA
switches
that
enables
bio‐chem‐photocatalytic
cascade‐driven
starvation‐photodynamic
synergistic
against
tumor
metastasis.
Emulating
compartmentalization
positional
assembly
strategies
found
living
cells,
this
nano‐organelle
reactor
allows
quantitative
co‐compartmentalization
multiple
functional
modules
designed
self‐illuminating
chemiexcited
PDT
system.
Within
space‐confined
nanoreactor,
biofuel
glucose
converted
hydrogen
peroxide
(H
2
O
)
which
enhances
luminol‐based
chemiluminescence
(CL),
consequently
driving
generation
photochemical
singlet
(
1
via
resonance
energy
transfer.
Meanwhile,
hemoglobin
functions
as
synchronized
supplier
both
oxidation
PDT,
while
also
exhibiting
peroxidase‐like
activity
produce
hydroxyl
radicals
(·OH).
Crucially,
keeps
switching
off
normal
tissues,
on‐demand
activation
tumors
through
toehold‐mediated
strand
displacement.
These
findings
demonstrate
self‐sufficient
precise
striking
tumors,
promising
paradigm
managing
highly
metastatic
cancers.
Analytical Chemistry,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 14, 2025
Surface-enhanced
Raman
spectroscopy
(SERS)
has
emerged
as
a
crucial
analytical
tool
in
the
field
of
oncology,
particularly
presenting
significant
challenges
for
diagnosis
and
treatment
head
neck
cancer.
This
Review
provides
an
overview
current
status
prospects
SERS
applications,
highlighting
their
profound
impact
on
molecular
biology-level
diagnosis,
tissue-level
identification,
HNC
therapeutic
monitoring,
integration
with
emerging
technologies.
The
application
single-molecule
assays
such
epidermal
growth
factor
receptors
PD-1/PD-L1,
gene
expression
analysis,
tumor
microenvironment
characterization
is
also
explored.
showcases
innovative
applications
liquid
biopsies
high-throughput
lateral
flow
analysis
ctDNA
quantification
salivary
diagnostics,
which
can
offer
rapid
highly
sensitive
suitable
immediate
detection.
At
tissue
level,
enables
cancer
cell
visualization
intraoperative
margin
enhancing
surgical
precision
decision-making.
role
radiotherapy,
chemotherapy,
targeted
therapy
examined
along
its
use
real-time
pharmacokinetic
studies
to
monitor
response.
Furthermore,
this
delves
into
synergistic
relationship
between
artificial
intelligence,
encompassing
machine
learning
deep
algorithms,
marking
dawn
new
era
oncology.
genomics,
metabolomics,
transcriptomics,
proteomics,
single-cell
omics
at
multiomics
level
will
revolutionize
our
comprehension
management
HNC.
offers
transformative
impacts
examines
future
directions
well
dynamic
research
field.
ABSTRACT
Metastasis
remains
a
leading
cause
of
cancer‐related
deaths,
defined
by
complex,
multi‐step
process
in
which
tumor
cells
spread
and
form
secondary
growths
distant
tissues.
Despite
substantial
progress
understanding
metastasis,
the
molecular
mechanisms
driving
this
development
effective
therapies
remain
incompletely
understood.
Elucidating
pathways
governing
metastasis
is
essential
for
discovery
innovative
therapeutic
targets.
The
rapid
advancements
sequencing
technologies
expansion
biological
databases
have
significantly
deepened
our
drivers
associated
drug
resistance.
This
review
focuses
on
particularly
roles
genetic
mutations,
epigenetic
changes,
post‐translational
modifications
progression.
We
also
examine
how
microenvironment
influences
metastatic
behavior
explore
emerging
strategies,
including
targeted
immunotherapies.
Finally,
we
discuss
future
research
directions,
stressing
importance
novel
treatment
approaches
personalized
strategies
to
overcome
improve
patient
outcomes.
By
integrating
contemporary
insights
into
basis
innovation,
provides
comprehensive
framework
guide
clinical
cancer.
Nature Communications,
Год журнала:
2025,
Номер
16(1)
Опубликована: Март 15, 2025
Multimodal
phototheranostics
utilizing
single
molecules
offer
a
"one-and-done"
approach,
presenting
convenient
and
effective
strategy
for
cancer
therapy.
However,
therapies
based
on
conventional
photosensitizers
often
suffer
from
limitations
such
as
photosensitizing
mechanism,
restricted
tumor
penetration
retention,
the
requirement
multiple
irradiations,
which
significantly
constrain
their
application.
In
this
report,
we
present
an
aggregation-induced
emission
luminogen
(AIEgen)
bacteria
hybrid
bionic
robot
to
address
above
issues.
This
is
composed
of
multifunctional
AIEgen
(INX-2)
Escherichia
coli
Nissle
1917
(EcN),
i.e.,
EcN@INX-2.
The
EcN@INX-2
exhibits
near-infrared
II
(NIR-II)
fluorescence
demonstrates
efficient
photodynamic
photothermal
effects,
well
tumor-targeting
capabilities.
These
features
are
facilitated
by
complementary
roles
INX-2
EcN.
successfully
enables
in
vivo
multimodal
imaging
therapy
colon
models
female
mice
through
various
mechanisms,
including
activation
anti-tumor
immunity,
Our
study
paves
avenue
designing
diagnostic
agents
targeted
image-guided
combinational
immunotherapy.
utility
hindered
need
limited
retention.
Here,
authors
these
issues
developing
that
activates
immunity.
Journal of Nanobiotechnology,
Год журнала:
2025,
Номер
23(1)
Опубликована: Март 22, 2025
Triple-negative
breast
cancer
(TNBC)
is
a
highly
aggressive
subtype
of
characterized
by
an
extremely
poor
prognosis.
Photoimmunotherapy
has
emerged
as
promising
strategy
for
the
treatment
TNBC.
This
approach
works
selectively
destroying
tumor
cells,
releasing
tumor-associated
antigens,
activating
immune
system,
and
effectively
inhibiting
proliferation
metastasis.
However,
majority
current
phototheranostic
approaches
are
hindered
limited
tissue
penetration
in
first
near-infrared
(NIR-I)
ultraviolet–visible
(UV–Vis)
regions.
Additionally,
due
to
lack
specific
subcellular
targets,
it
may
be
difficult
treat
deep-seated
lesions
with
ambiguous
extensive
boundaries
caused
TNBC
metastases.
Consequently,
development
effective,
deep-penetrating,
organelle-targeted
phototheranostics
essential
enhancing
outcomes
work
proposes
novel
molecular
design
NIR-II
realize
planar
rigid
conjugation
alkyl
chain
functionalization.
The
di-hexaalkyl
chains
vertical
configuration
on
donor
(4H-cyclopenta[2,1-b:3,4-b']
dithiophene)
shielding
units
(fluorene)
introduced
construct
S-D-A-D-S
type
(IR-FCD).
structure
IR-FCD
exhibits
robust
intramolecular
charge
transfer
capability,
lower
band
gap,
enhanced
photon
absorption
properties,
significant
steric
hindrance
from
vertically
arranged
minimize
non-radiative
energy
loss.
By
incorporating
N-(but-3-yn-1-yl)-4-methylbenzenesulfonamide
at
terminus
elongated
chain,
followed
self-assembly
into
DSPE-S-S-PEG2000,
excitable
(IR-FCD-Ts
NPs)
endoplasmic
reticulum
(ER)
targeting
capability
were
successfully
synthesized
imaging-guided
photoimmunotherapy
IR-FCD-Ts
NPs
demonstrate
exceptional
optical
characteristics,
maximum
1068
nm
(extending
1300
nm)
emission
1273
1700
nm),
along
high
molar
coefficient
2.76*104
L/mol·c
1064
aqueous
solution.
Under
exposure
laser
irradiation,
exhibit
superior
photothermal
properties
have
potential
photodynamic
therapy.
ER,
thereby
inducing
ER
stress
significantly
immunogenic
cell
death
(ICD)
triggers
strong
antitumor
response
inhibits
metastasis
Breast
cancer
(BC)
is
the
most
frequently
diagnosed
in
women
and
second
leading
cause
of
death
from
among
women.
Metastasis
major
BC-associated
mortality.
Accumulating
evidence
implicates
Caveolin-1
(Cav-1),
a
structural
protein
plasma
membrane
caveolae,
BC
metastasis.
Cav-1
exhibits
dual
role,
as
both
tumor
suppressor
promoter
depending
on
cellular
context
subtype.
This
review
highlights
role
modulating
glycolytic
metabolism,
tumor-stromal
interactions,
apoptosis,
senescence.
Additionally,
stromal
Cav-1's
expression
identified
potential
prognostic
marker,
offering
insights
into
its
contrasting
roles
suppression
progression.
Furthermore,
context-dependent
effects
are
explored
subtypes
including
hormone
receptor-positive,
HER2-positive,
triple-negative
(TNBC).
The
further
delves
regulating
metastatic
cascade
extracellular
matrix
cell
migration
invasion,
premetastatic
niche
formation.
later
sections
discuss
therapeutic
targeting
by
metabolic
inhibitors
such
betulinic
acid
compounds.
While
may
be
biomarker
target,
heterogeneous
context-specific
activity
necessitates
research
to
develop
precise
interventions.
Future
studies
investigating
mechanistic
metastasis
pave
way
for
effective
treatment
BC.